DS-1062a

datopotamab deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DS-1062a, covering 2024-04-03 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) [Phase 1]